Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Corporate Overview

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY, a unique, abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.


Pain Therapeutics Stock Information
Current Price: $5.41
Change - 2.17%  0.12
Day High $5.47
Day Low $5.28
Volume 155,300

4:00 PM ET on Jul 2, 2009
Quote delayed at least 20 minutes.

Stock price graph
3 Mo.   6 Mo.   1 Yr.

Recent Releases

Jun 4, 2009
Pain Therapeutics Invited to Present At Two Investor Conferences

May 5, 2009
Pain Therapeutics Initiates Clinical Study in Cancer Patients

View all releases »